Summary of Significant Accounting Policies - Additional Information (Details) - USD ($) |
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
Dec. 31, 2023 |
|
| Summary of Significant Accounting Policies [Line Items] | |||
| Goodwill impairment charges | $ 0 | $ 0 | $ 3,000,000 |
| Impairment of intangible assets | 0 | $ 0 | |
| Performance guarantee liabilities | $ 202,000 | ||
| Accounts receivable, payments term | 30 days | ||
| Number of shares excluded to calculate diluted net earnings per share as their effect would have been antidilutive | 1,583,723 | 1,048,351 | |
| Minimum | |||
| Summary of Significant Accounting Policies [Line Items] | |||
| Useful Life | 5 years | ||
| Maximum | |||
| Summary of Significant Accounting Policies [Line Items] | |||
| Useful Life | 10 years | ||
| Capitalized Software | Minimum | |||
| Summary of Significant Accounting Policies [Line Items] | |||
| Useful Life | 3 years | ||
| Capitalized Software | Maximum | |||
| Summary of Significant Accounting Policies [Line Items] | |||
| Useful Life | 5 years | ||
| X | ||||||||||
- Definition Represents the payments term of accounts receivable. No definition available.
|
| X | ||||||||||
- Definition Summary of significant accounting policies. No definition available.
|
| X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of transaction price allocated to performance obligation that has not been recognized as revenue. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|